Injectable Biopolymer for Diabetes Control

Duke University chemists have developed, at least experimentally, an extended release compound for treating Type 2 diabetes with a once a month injection. The compound combines a glucagon-like peptide 1 receptor agonist with an elastin-like polypeptide. Once injected, body heat slowly releases the drug which stimulates insulin production MORE